Universal Corp UVV
We take great care to ensure that the data presented and summarized in this overview for UNIVERSAL CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding UVV
View all-
Black Rock Inc. New York, NY3.78MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$158 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.91MShares$105 Million0.03% of portfolio
-
State Street Corp Boston, MA1.22MShares$66.9 Million0.0% of portfolio
-
First Trust Advisors LP Wheaton, IL1.08MShares$59.5 Million0.06% of portfolio
-
Richard Pzena Pzena Investment Management LLC929KShares$51 Million0.16% of portfolio
-
Invesco Ltd. Atlanta, GA794KShares$43.6 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA566KShares$31.1 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA543KShares$29.8 Million0.01% of portfolio
-
Morgan Stanley New York, NY364KShares$20 Million0.0% of portfolio
Latest Institutional Activity in UVV
Top Purchases
Top Sells
About UVV
Universal Corporation processes and supplies leaf tobacco and plant-based ingredients worldwide. The company operates through two segments, Tobacco Operations and Ingredients Operations. It is involved in the procuring, financing, processing, packing, storing, and shipping leaf tobacco for sale to manufacturers of consumer tobacco products. The company contracts, purchases, processes, and sells flue-cured, burley, and oriental tobaccos that are primarily used in the manufacture of cigarettes; and dark air-cured tobaccos principally used in the manufacture of cigars, natural wrapped cigars and cigarillos, smokeless, and pipe tobacco products. It also provides value-added services, including blending, chemical, and physical testing of tobacco; service cutting for various manufacturers; manufacturing reconstituted leaf tobacco; just-in-time inventory management services; electronic nicotine delivery systems; and smoke testing services for customers. In addition, the company offers testing services for crop protection agents and tobacco constituents in seed, leaf, and finished products, including e-cigarette liquids and vapors; and analytical services that include chemical compound testing in finished tobacco products and mainstream smoke. Further, it provides a various value-added manufacturing processes to produce specialty vegetable and fruit-based ingredients, as well as botanical extracts and flavorings for human and pet food markets; and recycles waste materials from tobacco production. The company was founded in 1886 and is headquartered in Richmond, Virginia.
Insider Transactions at UVV
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 01
2024
|
Preston Douglas Wigner Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
38,130
+29.1%
|
-
|
Aug 06
2024
|
Robert C Sledd Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,660
+12.96%
|
-
|
Aug 06
2024
|
Thomas H Tullidge Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,660
+13.62%
|
-
|
Aug 06
2024
|
Jacqueline T. Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,660
+16.03%
|
-
|
Aug 06
2024
|
Diana F Cantor Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,660
+9.61%
|
-
|
Aug 06
2024
|
Lennart R. Freeman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,660
+50.0%
|
-
|
Aug 06
2024
|
Thomas H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,660
+8.1%
|
-
|
Aug 06
2024
|
Michael T Lawton Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,660
+12.22%
|
-
|
Aug 06
2024
|
Arthur J. Schick Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,660
+29.96%
|
-
|
Jun 21
2024
|
George C Freeman Iii Chairman, President & CEO |
SELL
Bona fide gift
|
Direct |
5,400
-1.54%
|
-
|
May 30
2024
|
Mckeen Starke Senior VP & Sales Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,810
+25.97%
|
-
|
May 30
2024
|
Preston Douglas Wigner Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,178
-3.85%
|
$102,366
$47.3 P/Share
|
May 30
2024
|
Preston Douglas Wigner Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,729
+8.25%
|
-
|
May 30
2024
|
Catherine H Claiborne VP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,137
-4.58%
|
$53,439
$47.3 P/Share
|
May 30
2024
|
Catherine H Claiborne VP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
6,202
+11.73%
|
-
|
May 30
2024
|
Scott J Bleicher VP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
507
-4.46%
|
$23,829
$47.3 P/Share
|
May 30
2024
|
Scott J Bleicher VP & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
3,404
+13.99%
|
-
|
May 30
2024
|
John Patrick O'Keefe VP, Ingredients |
SELL
Payment of exercise price or tax liability
|
Direct |
616
-4.47%
|
$28,952
$47.3 P/Share
|
May 30
2024
|
John Patrick O'Keefe VP, Ingredients |
BUY
Grant, award, or other acquisition
|
Direct |
4,944
+15.77%
|
-
|
May 30
2024
|
Steven S. Diel VP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
495
+7.29%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 165K shares |
---|
Payment of exercise price or tax liability | 64K shares |
---|---|
Bona fide gift | 20.4K shares |
Open market or private sale | 5.95K shares |